The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
CEO Andrew Witty promised that UnitedHealthcare would work to speed up turnaround times for approval of some procedures and ...